Perindopril Impurity 21 | CAS 56558-30-6 - Request Quote
Perindopril Impurity 21
| SZ CAT No: | SZ-P018061 |
| CAS No | 56558-30-6 |
| Mol.F. | C6H13NO2 : HCl |
| Mol.Wt. | 131.2 : 36.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Perindopril Impurity 21 is chemically Methyl (S)-2-aminopentanoate hydrochloride. Perindopril Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Perindopril Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Perindopril.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 56558-30-6
Purchase 56558-30-6
Order 56558-30-6
Enquire 56558-30-6
price of 56558-30-6
56558-30-6 Supplier
56558-30-6 Manufacturer
56558-30-6 Exporter
buy high quality Perindopril Impurity 21
Purchase Perindopril Impurity 21
Perindopril Impurity 21 suppliers
Perindopril Impurity 21 manufacturers
Perindopril Impurity 21 price
Order Perindopril Impurity 21
Enquire Perindopril Impurity 21
Perindopril Impurity 21 cost
Perindopril Impurity 21 Supplier
Perindopril Impurity 21 Distributor
Perindopril Impurity 21 for Method Validation
Perindopril Reference Standard
Perindopril Impurity 21 for ANDA Filing
Perindopril Impurity 21 for Forced Degradation Studies
Perindopril Impurity 21 Identification Standards
Perindopril Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.